372 related articles for article (PubMed ID: 27725497)
21. Elucidating cell-penetrating peptide mechanisms of action for membrane interaction, cellular uptake, and translocation utilizing the hydrophobic counter-anion pyrenebutyrate.
Guterstam P; Madani F; Hirose H; Takeuchi T; Futaki S; El Andaloussi S; Gräslund A; Langel U
Biochim Biophys Acta; 2009 Dec; 1788(12):2509-17. PubMed ID: 19796627
[TBL] [Abstract][Full Text] [Related]
22. Arginine-Rich Cell-Penetrating Peptides Require Nucleolin and Cholesterol-Poor Subdomains for Translocation across Membranes.
Lorents A; Säälik P; Langel Ü; Pooga M
Bioconjug Chem; 2018 Apr; 29(4):1168-1177. PubMed ID: 29510042
[TBL] [Abstract][Full Text] [Related]
23. Membrane Internalization Mechanisms and Design Strategies of Arginine-Rich Cell-Penetrating Peptides.
Hao M; Zhang L; Chen P
Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012300
[TBL] [Abstract][Full Text] [Related]
24. Cell-penetrating peptides (CPPs) as a vector for the delivery of siRNAs into cells.
Nakase I; Tanaka G; Futaki S
Mol Biosyst; 2013 May; 9(5):855-61. PubMed ID: 23306408
[TBL] [Abstract][Full Text] [Related]
25. Cellular internalization kinetics of (luciferin-)cell-penetrating peptide conjugates.
Eiríksdóttir E; Mäger I; Lehto T; El Andaloussi S; Langel U
Bioconjug Chem; 2010 Sep; 21(9):1662-72. PubMed ID: 20684543
[TBL] [Abstract][Full Text] [Related]
26. On the importance of electrostatic interactions between cell penetrating peptides and membranes: a pathway toward tumor cell selectivity?
Jobin ML; Alves ID
Biochimie; 2014 Dec; 107 Pt A():154-9. PubMed ID: 25107405
[TBL] [Abstract][Full Text] [Related]
27. Syndecan-4 Is a Receptor for Clathrin-Mediated Endocytosis of Arginine-Rich Cell-Penetrating Peptides.
Kawaguchi Y; Takeuchi T; Kuwata K; Chiba J; Hatanaka Y; Nakase I; Futaki S
Bioconjug Chem; 2016 Apr; 27(4):1119-30. PubMed ID: 27019270
[TBL] [Abstract][Full Text] [Related]
28. Thermodynamics of lipid interactions with cell-penetrating peptides.
Sauder R; Seelig J; Ziegler A
Methods Mol Biol; 2011; 683():129-55. PubMed ID: 21053127
[TBL] [Abstract][Full Text] [Related]
29. Nanoscale Visualization of Morphological Alteration of Live-Cell Membranes by the Interaction with Oligoarginine Cell-Penetrating Peptides.
Ida H; Takahashi Y; Kumatani A; Shiku H; Murayama T; Hirose H; Futaki S; Matsue T
Anal Chem; 2021 Apr; 93(13):5383-5393. PubMed ID: 33769789
[TBL] [Abstract][Full Text] [Related]
30. Uptake pathways of cell-penetrating peptides in the context of drug delivery, gene therapy, and vaccine development.
Dowaidar M
Cell Signal; 2024 May; 117():111116. PubMed ID: 38408550
[TBL] [Abstract][Full Text] [Related]
31. Plasmid DNA delivery by arginine-rich cell-penetrating peptides containing unnatural amino acids.
Kato T; Yamashita H; Misawa T; Nishida K; Kurihara M; Tanaka M; Demizu Y; Oba M
Bioorg Med Chem; 2016 Jun; 24(12):2681-7. PubMed ID: 27132868
[TBL] [Abstract][Full Text] [Related]
32. Effect of the attachment of a penetration accelerating sequence and the influence of hydrophobicity on octaarginine-mediated intracellular delivery.
Takayama K; Hirose H; Tanaka G; Pujals S; Katayama S; Nakase I; Futaki S
Mol Pharm; 2012 May; 9(5):1222-30. PubMed ID: 22486588
[TBL] [Abstract][Full Text] [Related]
33. When cationic cell-penetrating peptides meet hydrocarbons to enhance in-cell cargo delivery.
Di Pisa M; Chassaing G; Swiecicki JM
J Pept Sci; 2015 May; 21(5):356-69. PubMed ID: 25787823
[TBL] [Abstract][Full Text] [Related]
34. Arginine-rich cell-penetrating peptides deliver gene into living human cells.
Liu BR; Lin MD; Chiang HJ; Lee HJ
Gene; 2012 Aug; 505(1):37-45. PubMed ID: 22669044
[TBL] [Abstract][Full Text] [Related]
35. Ionpair-π interactions favor cell penetration of arginine/tryptophan-rich cell-penetrating peptides.
Walrant A; Bauzá A; Girardet C; Alves ID; Lecomte S; Illien F; Cardon S; Chaianantakul N; Pallerla M; Burlina F; Frontera A; Sagan S
Biochim Biophys Acta Biomembr; 2020 Feb; 1862(2):183098. PubMed ID: 31676372
[TBL] [Abstract][Full Text] [Related]
36. Characterization of membrane penetration and cytotoxicity of C9orf72-encoding arginine-rich dipeptides.
Kanekura K; Harada Y; Fujimoto M; Yagi T; Hayamizu Y; Nagaoka K; Kuroda M
Sci Rep; 2018 Aug; 8(1):12740. PubMed ID: 30143685
[TBL] [Abstract][Full Text] [Related]
37. Neuroprotective peptides fused to arginine-rich cell penetrating peptides: Neuroprotective mechanism likely mediated by peptide endocytic properties.
Meloni BP; Milani D; Edwards AB; Anderton RS; O'Hare Doig RL; Fitzgerald M; Palmer TN; Knuckey NW
Pharmacol Ther; 2015 Sep; 153():36-54. PubMed ID: 26048328
[TBL] [Abstract][Full Text] [Related]
38. The influence of net charge and charge distribution on cellular uptake and cytosolic localization of arginine-rich peptides.
Fei L; Ren L; Zaro JL; Shen WC
J Drug Target; 2011 Sep; 19(8):675-80. PubMed ID: 21142649
[TBL] [Abstract][Full Text] [Related]
39. [Advances in the research and application of cell penetrating peptides].
Xie Y; Wang S; Yuan Q; Xie N
Sheng Wu Gong Cheng Xue Bao; 2019 Jul; 35(7):1162-1173. PubMed ID: 31328473
[TBL] [Abstract][Full Text] [Related]
40. Cell penetration: scope and limitations by the application of cell-penetrating peptides.
Reissmann S
J Pept Sci; 2014 Oct; 20(10):760-84. PubMed ID: 25112216
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
